SCHEMBL24720985

SCHEMBL24720985

Cc1ccc(S(=O)(=O)c2cccc(F)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.59
HTR2C P28335 2/20 0.53
HTR2B P41595 1/20 0.53
ABCC9 O60706 1/20 0.51
ABCC8 Q09428 1/20 0.51
KCNJ11 Q14654 1/20 0.51
KCNJ8 Q15842 1/20 0.51
HTT P42858 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HTR2A P28223 2/20 0.49
NFE2L2 Q16236 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
RAPGEF4 Q8WZA2 1/20 0.47
ACHE P22303 2/20 0.47
BCHE P06276 1/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7182433 0.86 HTR2A (0.60) GAAHTR2CHTR2BABCC9ABCC8
SCHEMBL775608 0.86 HTR2C (0.59) GAAHTR2CHTR2BABCC9ABCC8
SCHEMBL777135 0.84 HTR6 (0.61) GAAHTR2CHTR2BABCC9ABCC8
SCHEMBL6151129 0.82 GAA (0.67) GAAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL31038387 0.82 GAA (0.67) GAAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL8867135 0.81 HTR6 (0.59) HTR2CHTR2BABCC9ABCC8KCNJ11
SCHEMBL9459488 0.81 HTR2C (0.53) GAAHTR2CHTR2BABCC9ABCC8
SCHEMBL3446114 0.81 ALDH1A1 (0.59) GAAHTR2CHTR2BABCC9ABCC8
SCHEMBL4792586 0.80 GAA (0.76) GAAHTTL3MBTL1MEN1KMT2A
SCHEMBL4205906 0.79 HTR2C (0.54) GAAHTR2CHTR2BABCC9ABCC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2022-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK GAA 2227/4885HTR2C 3776/4885HTR2B 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.